Healthcare & Life Sciences
Curetis
Germanywww.curetis.com
Curetis is a Healthcare & Life Sciences startup based in Germany, most recent round Series B, 3 tracked investors.
Activeseries-b
series-b
Stage
3
Investors
About Curetis
Curetis is a company headquartered in Germany. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 3 investors associated with the company.
Curetis GmbH develops and provides the Unyvero A50, a rapid molecular diagnostic platform that identifies pathogens and resistance markers within 5 hours to support treatment decisions for severe infections.
Explore Curetis's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.